Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T21:53:11.949Z.
Calculation as of: 2026-10-06T21:53:11.949Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ee39d499936ebaa3412950651821bd8c7319a7e70273e63a1b15e5f1ca5028da
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Senseonics Holdings, Inc.
Market Cap
$416.27M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$418.95M
Free Cash Flow Yield
N/A
TTM Avg
2.75%
3Y Avg
2.75%
5Y Avg
2.75%
Market Cap
$419.87M
Free Cash Flow Yield
N/A
TTM Avg
4.42%
3Y Avg
4.42%
5Y Avg
4.42%
Market Cap
$411.21M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$411.00M
Free Cash Flow Yield
N/A
TTM Avg
0.50%
3Y Avg
0.50%
5Y Avg
0.50%
Market Cap
$422.86M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$424.10M
Free Cash Flow Yield
N/A
TTM Avg
3.29%
3Y Avg
4.78%
5Y Avg
5.98%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Senseonics Holdings, Inc. (SENS) | $416.27M | N/A | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $415.98M | N/A | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | N/A | 2.75% | 2.75% | 2.75% |
| Prothena Corporation plc (PRTA)vs › | $419.87M | N/A | 4.42% | 4.42% | 4.42% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | N/A | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | N/A | 0.50% | 0.50% | 0.50% |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | N/A | N/A | N/A | N/A |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | N/A | 3.29% | 4.78% | 5.98% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
